Greater than 100 million doses of COVID vaccines had been rejected in December, says UNICEF official, whereas 681 million shipped doses are unused in about 90 international locations.
Poorer nations final month rejected greater than 100 million doses of COVID-19 vaccines distributed by the worldwide programme COVAX, primarily resulting from their approaching expiry date, a UNICEF official has mentioned.
The determine exhibits the difficulties of vaccinating the worldwide inhabitants regardless of rising provides of jabs, with COVAX getting nearer to delivering one billion doses to a complete of almost 150 international locations.
“Greater than a 100 million have been rejected simply in December alone,” Etleva Kadilli, director of provide division at UN company UNICEF advised lawmakers on the European Parliament on Thursday.
The principle purpose for rejection was the supply of doses with a brief shelf-life, she mentioned.
Poorer nations have additionally been pressured to delay provides as a result of they’ve inadequate storage services, Kadilli mentioned, together with a scarcity of fridges for vaccines.
UNICEF didn’t instantly reply to a question about what number of doses have been rejected up to now in whole.
Along with rejected doses, many others sit unused in storage services in poorer nations.
UNICEF’s knowledge on provides and use of delivered vaccines present that 681 million shipped doses are at present unused in about 90 poorer nations internationally, in accordance with CARE, a charity, which extracted the figures from a public database.
Greater than 30 poorer nations, together with huge states such because the Democratic Republic of the Congo and Nigeria, have up to now used fewer than half of the doses they’ve acquired, CARE mentioned, citing UNICEF knowledge.
COVAX, the worldwide programme co-led by the World Well being Group, has up to now delivered 989 million COVID-19 vaccines to 144 international locations, in accordance with knowledge from GAVI, a vaccine alliance, which co-manages the programme.
COVAX is the primary provider of doses to dozens of poorer nations however isn’t the one one. Some international locations purchase doses on their very own or use different regional vaccine procurement programmes.
Provides to poorer nations have lengthy been very restricted due to the shortage of vaccines, as wealthier states secured a lot of the doses initially accessible from December 2020.
However within the final quarter, shipments have exponentially elevated because of donations from wealthy international locations which have vaccinated nearly all of their populations.
In January, 67 p.c of the inhabitants in richer nations had been totally vaccinated, whereas solely 8 p.c in poorer nations have acquired their first dose, WHO figures present.
The quicker tempo in provides caught many receiving international locations unprepared.
“We’ve international locations which might be pushing doses which might be at present accessible in direction of quarter two of 2022,” Kadilli mentioned.
Of the 15 million doses from the EU which have been refused, three-quarters had been AstraZeneca’s photographs with a shelf lifetime of lower than 10 weeks upon arrival, in accordance with a UNICEF slide proven to EU lawmakers.
Rich international locations donating vaccines with a comparatively brief shelf life has been a “main downside” for COVAX, a WHO senior official mentioned final month, as many doses had been wasted.
As much as a million vaccines had been estimated to have expired in Nigeria in November with out getting used.
The world faces but another variant ‘of concern’, close toly two years into the COVID-19 pandemic.
France and the UK report document national highs of recent coronavirus cases as Omicron variant continues to unfold.
Rise of Omicron presents new challenge to communities and governments as new 12 months approaches.